TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

Mise à jour : Il y a 4 ans
Référence : NCT00071097

Femme et Homme

Extrait

The purpose of this study is to determine the effectiveness, safety, and tolerability (how well the body stands the drug) of an investigational protease inhibitor (PI) called TMC114 given with low dose ritonavir.


Critère d'inclusion

  • HIV Infections

Liens